Evotec SE, DE0005664809

Evotec stock falls 4.12 percent ahead of the open

Published on 09/22/2026 at 07:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Evotec stock settled at EUR 2.79 after falling 4.12 percent in Frankfurt; the DAX gained 1.07 percent as the shares reached a five-year low.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage
Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec stock closed at EUR 2.79 on the Frankfurt Stock Exchange on September 21, 2026, down 4.12 percent. The shares underperformed the DAX, which gained 1.07 percent in the same session. Investing.com reported that Evotec reached a five-year low.

September 21, 2026 in numbers

Evotec SE (ISIN DE0005664809) closed at EUR 2.79 on the Frankfurt venue after losing EUR 0.12 during the session. The decline was recorded while the DAX rose 1.07 percent and the MDAX added 0.59 percent.

US-listed Evotec ADRs provided a separate venue reference: MarketBeat reported a September 21, 2026 intraday low of USD 1.56, a last trade of USD 1.5550 and volume of 99,869 shares, after a prior close of USD 1.60.

Evotec events today

MarketBeat lists the next Evotec earnings date as an estimate for November 5, 2026. The company-specific calendar does not provide an event within the next five trading days.

Disclaimer...

en | DE0005664809 | EVOTEC SE | boerse | 70150819 | bgmi